Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell.
Level 5 - mechanism / opinion, no new human data
Narrative review focused on biological mechanisms and theoretical molecular pathways.
What was done
This narrative review synthesizes published literature to explore the rationale and cellular mechanisms of pulsed electromagnetic field (PEMF) therapy, with a focus on chronic joint inflammation and arthritis. The authors examined clinical outcomes reported in existing literature and mapped potential endogenous bioelectric targets, including resting membrane potentials, charged membrane transporters, and voltage-gated calcium channels, to downstream intracellular signaling cascades.
What was found
The abstract provides no quantitative data, effect sizes, or meta-analytic numbers. Qualitatively, the review proposes that PEMF interacts with endogenous triggers such as resting membrane potential and resonance in membrane transporters, particularly activating voltage-gated calcium channels. This triggering is suggested to modulate nitric oxide production, moderate radical reactions, regulate transcription factors such as NF-κB, and ultimately downregulate inflammatory interleukins.
Why it matters
The review provides a theoretical and mechanistic framework connecting external electromagnetic field application to specific cell-surface targets and anti-inflammatory signaling pathways in joint disease.
Limits
The abstract reports no primary clinical or experimental data, systematic search protocol, or quantitative synthesis. Proposed cellular pathways represent narrative mechanism-based reasoning without direct proof of clinical efficacy or clear therapeutic dosing parameters.
Cited by
- contradicts Pulsed electromagnetic field (PEMF) therapy depolarizes cells via an influx of negative ions, improving blood flow and cell membrane charge.